PULMATRIX is committed to the development and commercialization of novel and transformational medicines for patients all over the world, using our proprietary iSPERSE™ technology to optimally deliver both respiratory and non-respiratory therapies via the respiratory system.
Looking for a particular Pulmatrix Inc. employee's phone or email?
The Pulmatrix Inc. annual revenue was $7 million in 2026.
Peter Ludlum is the Interim Chief Executive Officer of Pulmatrix Inc..
5 people are employed at Pulmatrix Inc..
Pulmatrix Inc. is based in Bedford, Massachusetts.
The NAICS codes for Pulmatrix Inc. are [325, 32541, 5417, 3254, 541, 54, 32].
The SIC codes for Pulmatrix Inc. are [28, 283].